2023
DOI: 10.3389/fimmu.2023.1111719
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers in autoimmune diseases of the central nervous system

Abstract: The autoimmune diseases of the central nervous system (CNS) represent individual heterogeneity with different disease entities. Although clinical and imaging features make it possible to characterize larger patient cohorts, they may not provide sufficient evidence to detect disease activity and response to disease modifying drugs. Biomarkers are becoming a powerful tool due to their objectivity and easy access. Biomarkers may indicate various aspects of biological processes in healthy and/or pathological state… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 108 publications
0
2
0
Order By: Relevance
“…Because of the heterogeneous nature of autoimmune diseases, diagnosis of affected organs is necessary. In addition to the approach by detecting organ-specific protein markers (Suzuki et al, 2008; Zhang, Gao, Liu, & Zhang, 2023) (e.g. Neurofilament light chain in multiple sclerosis), it would be desirable to be able to use TCR repertoire analysis for diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…Because of the heterogeneous nature of autoimmune diseases, diagnosis of affected organs is necessary. In addition to the approach by detecting organ-specific protein markers (Suzuki et al, 2008; Zhang, Gao, Liu, & Zhang, 2023) (e.g. Neurofilament light chain in multiple sclerosis), it would be desirable to be able to use TCR repertoire analysis for diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…Because of the heterogeneous nature of autoimmune diseases, diagnosis of affected organs is necessary. In addition to the approach by detecting organ-specific protein markers (Suzuki et al, 2008;Zhang et al, 2023) (e.g., Neurofilament light chain in multiple sclerosis), it would be desirable to be able to use TCR repertoire analysis for diagnosis. TCR repertoire is formed by a combination of the hypervariable complementaritydetermining region 3 (CDR3) loop of TCRs on their cell membranes and diverse V(D)J recombination in the thymus, allowing T cells to recognize myriad antigens in the body (Schatz & Ji, 2011).…”
mentioning
confidence: 99%